Direktorat Registrasi ObatValid

CEFIXIME TRIHYDRATE

by '-'

BPOM Number: GKL1014812001A1
Approved: 10 January 2025
Expiry: 31 October 2028
Form: Capsule

About This Registration

CEFIXIME TRIHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1014812001A1. Its current registration status is Valid, with the licence valid until 31 October 2028. The product is registered to MEDIKON PRIMA LABORATORIES - INDONESIA. BPOM first approved this registration in December 2024. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 5 STRIP @ 10 KAPSUL
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

MEDIKON PRIMA LABORATORIES - INDONESIA
KAB. TANGERANG
NPWP: 013180096415000
owner
View profile →

Manufacturing Sites

MEDIKON PRIMA LABORATORIES - INDONESIA
KAB. TANGERANG
primary
View profile →

Market Intelligence

Owner Portfolio: MEDIKON PRIMA LABORATORIES - INDONESIA holds 36 BPOM registrations
Manufacturer Scale: MEDIKON PRIMA LABORATORIES - INDONESIA produces 36 registered products
Registration Age: Registered for 1 year, 8 months

FDA Cross-Reference

via openFDA

Generic Name: CEFIXIME
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?